DxDiscovery, Inc.

DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as prophylactics/therapeutics for infectious disease. Our diagnostics portfolio includes products that will improve situations where current standard-of-care is time-consuming or has a high likelihood of producing an inaccurate result. The test platform is an immunoassay in which antibodies are used for biomarker detection. We discover the biomarkers and develop the antibodies that are central to assay construction.